Active substance
Mupirocin
- SFDA 6
- US FDA 17
- Health Canada 2
- US price lines 4
- NHS prices 3
- WHO EML 1
- Safety 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AVOBAN 2% W-W OINTMENT | 2 % | Ointment · Topical | 1 Tube | SAR 19.40 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| AVOBAN 2% W-W OINTMENT | 2 % | Ointment · Topical | 1 Tube | SAR 38.80 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| AVOBAN 2% nasal ointment | 2 % | Nasal ointment · Nasal use | 1 Tube | SAR 28.45 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| Avoban | 2 % | Cream · Topical | 1 Tube | SAR 38.80 | NCE · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| BACTROBAN NASAL OINTMENT 2% | 2 % | Nasal ointment · Nasal use | 1 Tube | SAR 35.05 | NCE · Prescription | Glaxo Saudi Arabia Ltd. | Valid |
| BACTROBAN OINT 2% | 2 % | Ointment · Topical | 1 Tube | SAR 27.70 | NCE · Prescription | Glaxo Saudi Arabia Ltd | Valid |
Indications — CHI Daman Drug Formulary
BACTERIAL SKIN INFECTIONS - IMPETIGO AND ECTHYMA; ECZEMA; EPIDERMOLYSIS BULLOSA; HIP AND KNEE REPLACEMENT SURGERY
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MUPIROCIN | 2% | ointment · topical | TEVA | Prescription | 7 Nov 2003 |
| MUPIROCIN | 2% | ointment · topical | PADAGIS ISRAEL | Prescription | 7 Nov 2003 |
| MUPIROCIN | 2% | ointment · topical | SUN PHARMA CANADA | Prescription | 23 Sep 2005 |
| MUPIROCIN | 2% | ointment · topical | FOUGERA PHARMS | Prescription | 30 Nov 2005 |
| MUPIROCIN | 2% | ointment · topical | GLENMARK PHARMS | Prescription | 8 Jun 2011 |
| MUPIROCIN | EQ 2% BASE | cream · topical | GLENMARK PHARMS | Prescription | 24 Jan 2013 |
| MUPIROCIN | EQ 2% BASE | cream · topical | SUN PHARMA CANADA | Prescription | 27 Apr 2020 |
| MUPIROCIN | EQ 2% BASE | cream · topical | ENCUBE | Prescription | 31 Aug 2021 |
| MUPIROCIN | EQ 2% BASE | cream · topical | ALEMBIC | Prescription | 16 Nov 2021 |
| MUPIROCIN | EQ 2% BASE | cream · topical | AMNEAL | Prescription | 15 Nov 2022 |
| MUPIROCIN | 2% | ointment · topical | ENCUBE | Prescription | 13 May 2025 |
| MUPIROCIN CALCIUM | EQ 2% BASE | cream · topical | ZYDUS LIFESCIENCES | Prescription | 29 Sep 2026 |
| BACTROBAN | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ointment · topical | GLAXOSMITHKLINE | Discontinued | 31 Dec 1987 |
| BACTROBAN | EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ointment · nasal | GLAXOSMITHKLINE | Discontinued | 18 Sep 1995 |
| BACTROBAN | EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream · topical | GLAXOSMITHKLINE | Discontinued | 11 Dec 1997 |
| CENTANY | 2% | ointment · topical | PADAGIS US | Discontinued | 4 Dec 2002 |
| MUPIROCIN | EQ 2% BASE | cream · topical | PADAGIS ISRAEL | Discontinued | 3 Aug 2022 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| STRAMUCIN | 02483459 | 2 % / W/W | CREAM · TOPICAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| TARO-MUPIROCIN | 02279983 | 2 % | OINTMENT · TOPICAL | TARO PHARMACEUTICALS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | MUPIROCIN 2% CREAM | $0.82599 | per GM | 23 Sep 2026 |
| US NADAC | MUPIROCIN 2% CREAM | $0.88299 | per GM | 23 Sep 2026 |
| US NADAC | MUPIROCIN 2% OINTMENT | $0.14555 | per GM | 23 Sep 2026 |
| US NADAC | MUPIROCIN 2% OINTMENT | $0.29847 | per GM | 23 Sep 2026 |
| NHS Drug Tariff | Mupirocin 2% cream | £5.26 | 15 gram | 1 Oct 2026 |
| NHS Drug Tariff | Mupirocin 2% nasal ointment | £4.24 | 3 gram | 1 Oct 2026 |
| NHS Drug Tariff | Mupirocin 2% ointment | £7.76 | 15 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 13.2. Dermatological medicines > Anti-infective medicines · core
Superficial bacterial folliculitis; Impetigo
Local > Topical > Cream: 2% (as mupirocin calcium) | Local > Topical > Ointment: 2%
Safety signals and safety-related labeling changes
- US FDA 10 Jul 2025 CENTANY — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 8 May 2017 BACTROBAN — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 8 May 2017 BACTROBAN — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 8 May 2017 BACTROBAN — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.